153 related articles for article (PubMed ID: 17163581)
21. The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells.
Priyadarsini RV; Murugan RS; Sripriya P; Karunagaran D; Nagini S
Free Radic Res; 2010 Jun; 44(6):624-34. PubMed ID: 20429769
[TBL] [Abstract][Full Text] [Related]
22. Disruption of Epigenetic Silencing in Human Colon Cancer Cells Lines Utilizing a Novel Supercritical CO
Qiu Z; Andrijauskaite K; Morris J; Wargovich MJ
Anticancer Res; 2019 Oct; 39(10):5473-5481. PubMed ID: 31570441
[TBL] [Abstract][Full Text] [Related]
23. Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growth.
Karkare S; Chhipa RR; Anderson J; Liu X; Henry H; Gasilina A; Nassar N; Ghosh J; Clark JP; Kumar A; Pauletti GM; Ghosh PK; Dasgupta B
Clin Cancer Res; 2014 Jan; 20(1):199-212. PubMed ID: 24170547
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic mechanisms and the hallmarks of cancer: an intimate affair.
Darwiche N
Am J Cancer Res; 2020; 10(7):1954-1978. PubMed ID: 32774995
[TBL] [Abstract][Full Text] [Related]
25. Nimbolide prevents myocardial damage by regulating cardiac biomarkers, antioxidant level, and apoptosis signaling against doxorubicin-induced cardiotoxicity in rats.
Li H; Xia B; Chen W; Zhang Y; Gao X; Chinnathambi A; Alharbi SA; Zhao Y
J Biochem Mol Toxicol; 2020 Sep; 34(9):e22543. PubMed ID: 32627270
[TBL] [Abstract][Full Text] [Related]
26. Nimbolide abrogates cerulein-induced chronic pancreatitis by modulating β-catenin/Smad in a sirtuin-dependent way.
Bansod S; Aslam Saifi M; Khurana A; Godugu C
Pharmacol Res; 2020 Jun; 156():104756. PubMed ID: 32194177
[TBL] [Abstract][Full Text] [Related]
27. Harnessing the Phytotherapeutic Treasure Troves of the Ancient Medicinal Plant Azadirachta indica (Neem) and Associated Endophytic Microorganisms.
Kharwar RN; Sharma VK; Mishra A; Kumar J; Singh DK; Verma SK; Gond SK; Kumar A; Kaushik N; Revuru B; Kusari S
Planta Med; 2020 Sep; 86(13-14):906-940. PubMed ID: 32126583
[No Abstract] [Full Text] [Related]
28. Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment.
Teleanu RI; Chircov C; Grumezescu AM; Teleanu DM
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31905724
[TBL] [Abstract][Full Text] [Related]
29. Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells.
Patra A; Satpathy S; Hussain MD
Int J Nanomedicine; 2019; 14():8095-8104. PubMed ID: 31632020
[TBL] [Abstract][Full Text] [Related]
30. The Highly Pure Neem Leaf Extract, SCNE, Inhibits Tumorigenesis in Oral Squamous Cell Carcinoma via Disruption of Pro-tumor Inflammatory Cytokines and Cell Signaling.
Morris J; Gonzales CB; De La Chapa JJ; Cabang AB; Fountzilas C; Patel M; Orozco S; Wargovich MJ
Front Oncol; 2019; 9():890. PubMed ID: 31572681
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of antiarthritic activity of nimbolide against Freund's adjuvant induced arthritis in rats.
Cui X; Wang R; Bian P; Wu Q; Seshadri VDD; Liu L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3391-3398. PubMed ID: 31394949
[TBL] [Abstract][Full Text] [Related]
32. Nimbolide Represses the Proliferation, Migration, and Invasion of Bladder Carcinoma Cells via Chk2-Mediated G2/M Phase Cell Cycle Arrest, Altered Signaling Pathways, and Reduced Transcription Factors-Associated MMP-9 Expression.
Shin SS; Hwang B; Muhammad K; Gho Y; Song JH; Kim WJ; Kim G; Moon SK
Evid Based Complement Alternat Med; 2019; 2019():3753587. PubMed ID: 31391858
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic effects of Nimbolide, an autophagy regulator, in ameliorating pulmonary fibrosis through attenuation of TGF-β1 driven epithelial-to-mesenchymal transition.
Prashanth Goud M; Bale S; Pulivendala G; Godugu C
Int Immunopharmacol; 2019 Oct; 75():105755. PubMed ID: 31377591
[TBL] [Abstract][Full Text] [Related]
34. Harnessing the anti-cancer natural product nimbolide for targeted protein degradation.
Spradlin JN; Hu X; Ward CC; Brittain SM; Jones MD; Ou L; To M; Proudfoot A; Ornelas E; Woldegiorgis M; Olzmann JA; Bussiere DE; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Maimone TJ; Nomura DK
Nat Chem Biol; 2019 Jul; 15(7):747-755. PubMed ID: 31209351
[TBL] [Abstract][Full Text] [Related]
35. Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-β and EMT/Slug signalling.
Annaldas S; Saifi MA; Khurana A; Godugu C
Mol Immunol; 2019 Aug; 112():247-255. PubMed ID: 31202101
[TBL] [Abstract][Full Text] [Related]
36. Natural products as multidrug resistance modulators in cancer.
Kumar A; Jaitak V
Eur J Med Chem; 2019 Aug; 176():268-291. PubMed ID: 31103904
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation.
Mahmoud N; Saeed MEM; Sugimoto Y; Klauck SM; Greten HJ; Efferth T
Oncotarget; 2018 Nov; 9(87):35762-35779. PubMed ID: 30515268
[TBL] [Abstract][Full Text] [Related]
38. Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer.
Sophia J; Kowshik J; Dwivedi A; Bhutia SK; Manavathi B; Mishra R; Nagini S
Cell Death Dis; 2018 Oct; 9(11):1087. PubMed ID: 30352996
[TBL] [Abstract][Full Text] [Related]
39. Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells.
Hsueh KC; Lin CL; Tung JN; Yang SF; Hsieh YH
Environ Toxicol; 2018 Sep; 33(9):913-922. PubMed ID: 29962003
[TBL] [Abstract][Full Text] [Related]
40. First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC/MS method.
Baira SM; Khurana A; Somagoni J; Srinivas R; Godugu C; Talluri MVNK
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():191-198. PubMed ID: 29908468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
